Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem
- PMID: 23201432
- DOI: 10.1016/j.tem.2012.10.006
Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem
Abstract
Cachexia has a devastating impact on survival and quality of life for many cancer patients. A better understanding of the underlying mechanisms leading to the complex metabolic defects of cachexia, coupled with effective treatment options, will improve management of wasting in cancer patients. The growing appreciation that cancer cachexia results from the spillover effects of cytokine production by tumors on the integrated regulation of energy balance in different organs identifies potential therapeutic options. However, targeting such tumorkines requires a comprehensive understanding of their normal as well as pathophysiological functions, especially the crosstalk between inflammatory signaling and metabolic dysregulation. Recent advances in characterizing the surprising parallels between obesity and cancer cachexia provide new insights into these apparently divergent syndromes.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Adipose tissue inflammation and cancer cachexia: the role of steroid hormones.Horm Mol Biol Clin Investig. 2014 Jan;17(1):5-12. doi: 10.1515/hmbci-2013-0040. Horm Mol Biol Clin Investig. 2014. PMID: 25372726 Review.
-
[Feeding-related disorders in medicine, with special reference to cancer anorexia-cachexia syndrome].Rinsho Byori. 2006 Oct;54(10):1044-51. Rinsho Byori. 2006. PMID: 17133993 Review. Japanese.
-
Cancer-associated cachexia and underlying biological mechanisms.Annu Rev Nutr. 2006;26:435-61. doi: 10.1146/annurev.nutr.26.061505.111151. Annu Rev Nutr. 2006. PMID: 16602932 Review.
-
[Recent development in research and management of cancer anorexia-cachexia syndrome].Gan To Kagaku Ryoho. 2005 Jun;32(6):743-9. Gan To Kagaku Ryoho. 2005. PMID: 15984510 Review. Japanese.
-
Protein and amino acid metabolism in cancer cachexia: investigative techniques and therapeutic interventions.Crit Rev Clin Lab Sci. 1993;30(3):223-72. doi: 10.3109/10408369309084669. Crit Rev Clin Lab Sci. 1993. PMID: 8260072 Review.
Cited by
-
Overall survival and short-term efficacy analysis of cervical squamous cell carcinoma with skeletal muscle and 18F-FDG PET/CT parameters.Sci Rep. 2024 Feb 27;14(1):4809. doi: 10.1038/s41598-024-55268-2. Sci Rep. 2024. PMID: 38413662 Free PMC article.
-
Effects of Fermented Polygonum cuspidatum on the Skeletal Muscle Functions.Nutrients. 2024 Jan 19;16(2):305. doi: 10.3390/nu16020305. Nutrients. 2024. PMID: 38276543 Free PMC article.
-
Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy.BMC Cancer. 2023 Nov 2;23(1):1055. doi: 10.1186/s12885-023-11540-8. BMC Cancer. 2023. PMID: 37919691 Free PMC article.
-
Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.J Cachexia Sarcopenia Muscle. 2023 Dec;14(6):2591-2601. doi: 10.1002/jcsm.13333. Epub 2023 Sep 19. J Cachexia Sarcopenia Muscle. 2023. PMID: 37724690 Free PMC article.
-
Standard Hypercaloric, Hyperproteic vs. Leucine-Enriched Oral Supplements in Patients with Cancer-Induced Sarcopenia, a Randomized Clinical Trial.Nutrients. 2023 Jun 12;15(12):2726. doi: 10.3390/nu15122726. Nutrients. 2023. PMID: 37375630 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
